Oppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35

Benzinga · 3d ago
Oppenheimer analyst Les Sulewski assumes Innoviva (NASDAQ:INVA) with a Outperform rating and announces Price Target of $35.